BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10139487)

  • 1. Health care technology as a policy issue.
    Banta HD
    Health Policy; 1994; 30(1-3):1-21. PubMed ID: 10139487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from the eight countries.
    Battista RN; Banta HD; Jonnson E; Hodge M; Gelband H
    Health Policy; 1994; 30(1-3):397-421. PubMed ID: 10139496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special issue: Health care technology and its assessment in eight countries: Australia, Canada, France, Germany, Netherlands, Sweden, United Kingdom, United States.
    Health Policy; 1994; 30(1-3):1-421. PubMed ID: 10139488
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of health care technology assessment. An international perspective.
    Battista RN; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(2):287-300. PubMed ID: 7790172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care technology in France.
    Weill C
    Health Policy; 1994; 30(1-3):123-62. PubMed ID: 10139489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care expenditures in nine industrialized countries, 1960-76.
    Simanis JG; Coleman JR
    Soc Secur Bull; 1980 Jan; 43(1):3-8. PubMed ID: 6769168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing medical technology: lessons for the United States from Quebec and France.
    Rosenau PV
    Int J Health Serv; 2000; 30(3):617-39. PubMed ID: 11109185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care cost containment strategies used in four other high-income countries hold lessons for the United States.
    Stabile M; Thomson S; Allin S; Boyle S; Busse R; Chevreul K; Marchildon G; Mossialos E
    Health Aff (Millwood); 2013 Apr; 32(4):643-52. PubMed ID: 23569043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment of cancer drugs in Canada, the United Kingdom and Australia: should the United States take notice?
    Dranitsaris G; Papadopoulos G
    Appl Health Econ Health Policy; 2015 Jun; 13(3):291-302. PubMed ID: 25274258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.
    Rand LZ; Kesselheim AS
    J Law Med Ethics; 2020 Sep; 48(3):583-594. PubMed ID: 33021189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care technology in Sweden.
    Jonsson E; Banta HD
    Health Policy; 1994; 30(1-3):257-94. PubMed ID: 10139493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International diffusion of new health technologies: a ten-country analysis of six health technologies.
    Packer C; Simpson S; Stevens A;
    Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care technology in Canada (with special reference to Quebec).
    Battista RN; Jacob R; Hodge MJ
    Health Policy; 1994; 30(1-3):73-122. PubMed ID: 10139497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care technology in Australia.
    Hailey D
    Health Policy; 1994; 30(1-3):23-72. PubMed ID: 10139492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers.
    Banta HD; Vondeling H
    Soc Sci Med; 1994 Jun; 38(12):1663-74. PubMed ID: 8047925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care technology in The Netherlands.
    Bos M
    Health Policy; 1994; 30(1-3):207-55. PubMed ID: 10139491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical industry's perspective on health technology assessment.
    Lothgren M; Ratcliffe M
    Int J Technol Assess Health Care; 2004; 20(1):97-101. PubMed ID: 15176185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and diffusion of excimer laser treatment of myopia in the United States and in The Netherlands.
    Vondeling H; Rosendal H; Banta D
    Health Policy; 1995 Oct; 34(1):21-33. PubMed ID: 10151963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.